Inflammation, insulin resistance and neuroprogression in depression
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Chronic low-grade inflammation has been observed in major depression and other major psychiatric disorders and has been implicated in metabolic changes that are commonly associated with these disorders. This raises the possibility that the effects of dysfunctional metabolism may facilitate changes in neuronal structure and function which contribute to neuroprogression. Such changes may have implications for the progress from major depression to dementia in the elderly patient. The purpose of this review is to examine the contribution of inflammation and hypercortisolaemia, which are frequently associated with major depression, to neurodegeneration and how they detrimentally impact on brain energy metabolism. A key factor in these adverse events is insulin insensitivity caused by pro-inflammatory cytokines in association with desensitised glucocorticoid receptors. Identifying the possible metabolic changes initiated by inflammation opens new targets to ameliorate the adverse metabolic changes. This has resulted in the identification of dietary and drug targets which are of interest in the development of a new generation of psychotropic drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07495-8 · Cited by 4,492 · cited 1×
“Major depression and co-morbid medical illness Major depression (MDD) is a leading cause of disability worldwide and, according to the World Health Organisation, will become the leading cause of disability-adjusted life years by 2030 (Murray & Lopez, 1997; Moussavi et al., 2007; WHO, 2018).”
BackgroundOverweight, Obesity, and Depression: A Systematic Review and Meta-analysis of Longitudinal Studies
Luppino, F. S., de Wit, L. M., Bouvy, P. F., Stijnen, T., Cuijpers, P., Penninx, B. W. J. H., & Zitman, F. G. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.2 · Cited by 4,322 · cited 1×
“A meta-analysis of longitudinal studies showed that obesity increases the risk of MDD (OR = 1.22–1.98) and vice versa (OR = 1.33–1.87) (Luppino et al., 2010).”
BackgroundInfluentialDepression, chronic diseases, and decrements in health: results from the World Health Surveys
Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., & Ustun, B. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61415-9 · Cited by 4,070
The Prevalence of Comorbid Depression in Adults With Diabetes
Anderson, R. J., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.6.1069 · Cited by 3,926 · cited 1×
“Similar data exist for DM2: the prevalence of MDD in patients with DM2 is higher than expected (OR = 1.6–2.0) (Anderson et al., 2001; Ali et al., 2006) and vice versa (RR= 1.29–1.72) (Vancampfort et al., 2015).”
BackgroundInfluentialSugar for the brain: the role of glucose in physiological and pathological brain function
Mergenthaler, P., Lindauer, U., Dienel, G. A., & Meisel, A. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.07.001 · Cited by 1,612
Depression and Type 2 Diabetes Over the Lifespan
Mezuk, B., Eaton, W. W., Albrecht, S., & Golden, S. H. (2008) · Diabetes Care · doi:10.2337/dc08-0985 · Cited by 1,558 · cited 1×
“Several meta-analyses of longitudinal studies confirm that DM2 and MDD are indeed independent risk factors for each other (Knol et al., 2006; Mezuk et al., 2008; Nouwen et al., 2010; Rotella & Mannucci, 2013).”
BackgroundOwnby, R. L., Crocco, E., Acevedo, A., John, V., & Loewenstein, D. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.5.530 · Cited by 1,493 · cited 1×
“It has been estimated that the risk of Alzheimer’s disease is approximately doubled in patients with major depression (Ownby et al., 2006).”
BackgroundScaling-up treatment of depression and anxiety: a global return on investment analysis
Chisholm, D., Sweeny, K., Sheehan, P., Rasmussen, B., Smit, F., Cuijpers, P., & Saxena, S. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30024-4 · Cited by 1,451 · cited 1×
“Importantly, expected returns to investment in understanding and intervention are substantial (Chisholm et al., 2016).”
BackgroundRelationship between interferon‐γ, indoleamine 2,3‐dioxygenase, and tryptophan catabolism
Taylor, M. W., & Feng, G. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.11.1907934 · Cited by 1,060
Depression and Diabetes Treatment Nonadherence: A Meta-Analysis
Gonzalez, J. S., Peyrot, M., McCarl, L. A., Collins, E. M., Serpa, L., Mimiaga, M. J., & Safren, S. A. (2008) · Diabetes Care · doi:10.2337/dc08-1341 · Cited by 1,060 · cited 1×
“Unfortunately, co-morbid depression in DM2 is associated with poor compliance to anti-diabetic treatment, increased mortality and a higher frequency of diabetic complications (Lustman et al., 2000; Katon et al., 2005; Gonzalez et al., 2008; Heckbert et al., 2010).”
BackgroundLiu, Y., Ho, R. C.-M., & Mak, A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.08.003 · Cited by 948
for the European Depression in Diabetes (EDID) Research Consortium, Nouwen, A., Winkley, K., Twisk, J., Lloyd, C. E., Peyrot, M., Ismail, K., & Pouwer, F. (2010) · Diabetologia · doi:10.1007/s00125-010-1874-x · Cited by 756
Stress, Glucocorticoids, and Damage to the Nervous System: The Current State of Confusion
Sapolsky, R. M. (1996) · Stress · doi:10.3109/10253899609001092 · Cited by 738 · cited 2×
“The increased activity of the HPA axis induced by stress is compounded by the effects of pro-inflammatory cytokines (Sapolsky, 1996; Leonard, 2011, 2018; Lotrich, 2015).”
BackgroundResultThe Association of Comorbid Depression With Mortality in Patients With Type 2 Diabetes
Katon, W. J., Rutter, C., Simon, G., Lin, E. H. B., Ludman, E., Ciechanowski, P., Kinder, L., Young, B., & Von Korff, M. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2668 · Cited by 640 · cited 1×
“Unfortunately, co-morbid depression in DM2 is associated with poor compliance to anti-diabetic treatment, increased mortality and a higher frequency of diabetic complications (Lustman et al., 2000; Katon et al., 2005; Gonzalez et al., 2008; Heckbert et al., 2010).”
BackgroundMiller, G. E., Chen, E., Sze, J., Marin, T., Arevalo, J. M. G., Doll, R., Ma, R., & Cole, S. W. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.03.017 · Cited by 552 · cited 1×
“Although the glucocorticoids are acutely anti-inflammatory, in depression and chronic stressful situations, the peripheral and central glucocorticoid receptors become insensitive due to the internalisation of the receptors from the cell surface (Miller et al., 2008).”
BackgroundGuillemin, G. J., Smythe, G., Takikawa, O., & Brew, B. J. (2005) · Glia · doi:10.1002/glia.20090 · Cited by 497 · cited 3×
“Under non-inflammatory conditions, the end product of kynureninemetabolism is kynurenic acid, but following the activation of the microglia by stress or inflammation, the neurodegenerative pathway predominates (Guillemin et al., 2005).”
BackgroundHeartache and heartbreak—the link between depression and cardiovascular disease
Nemeroff, C. B., & Goldschmidt-Clermont, P. J. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.91 · Cited by 424 · cited 1×
“Heart disorders have also been described as occurring with a greater frequency in chronically depressed patients (Cowles et al., 2009; Nemeroff & Goldschmidt-Clermont, 2012; Sotelo & Nemeroff, 2017).”
BackgroundInflammation and depression: a causal or coincidental link to the pathophysiology?
Leonard, B. E. (2018) · Acta Neuropsychiatrica · doi:10.1017/neu.2016.69 · Cited by 409
Self-citationInflammation and Alzheimer’s disease
Lee, Y.-J., Han, S. B., Nam, S.-Y., Oh, K.-W., & Hong, J. T. (2010) · Archives of Pharmacal Research · doi:10.1007/s12272-010-1006-7 · Cited by 396
Depression as a Risk Factor for Diabetes: A Meta-Analysis of Longitudinal Studies
Rotella, F., & Mannucci, E. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12r07922 · Cited by 360
Should Depressive Syndromes Be Reclassified as “Metabolic Syndrome Type II”?
McIntyre, R. S., Soczynska, J. K., Konarski, J. Z., Woldeyohannes, H. O., Law, C. W. Y., Miranda, A., Fulgosi, D., & Kennedy, S. H. (2007) · Annals of Clinical Psychiatry · doi:10.1080/10401230701653377 · Cited by 277 · cited 1×
“The close association between the depression and the metabolic syndrome led McIntyre and co-workers to classify depressive syndromes as metabolic syndrome type 2 (McIntyre et al., 2007).”
BackgroundCunnane, S. C., Courchesne‐Loyer, A., St‐Pierre, V., Vandenberghe, C., Pierotti, T., Fortier, M., Croteau, E., & Castellano, C. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12999 · Cited by 250
Differential vulnerability of central neurons of the rat to quinolinic acid
Schwarcz, R., & Köhler, C. (1983) · Neuroscience Letters · doi:10.1016/0304-3940(83)90115-5 · Cited by 239
Expression of interleukin-18 is increased in the brains of Alzheimer’s disease patients
Ojala, J., Alafuzoff, I., Herukka, S.-K., van Groen, T., Tanila, H., & Pirttilä, T. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.06.006 · Cited by 235
Overweight and Obesity Affect Treatment Response in Major Depression
Kloiber, S., Ising, M., Reppermund, S., Horstmann, S., Dose, T., Majer, M., Zihl, J., Pfister, H., Unschuld, P. G., Holsboer, F., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.10.001 · Cited by 208 · cited 1×
“Moreover, being obese is associated with a lower response to antidepressant treatment (Papakostas et al., 2005; Kloiber et al., 2007; Oskooilar et al., 2009; Uher et al., 2009).”
BackgroundVancampfort, D., Mitchell, A. J., De Hert, M., Sienaert, P., Probst, M., Buys, R., & Stubbs, B. (2015) · Depression and Anxiety · doi:10.1002/da.22387 · Cited by 171 · cited 1×
“Similar data exist for DM2: the prevalence of MDD in patients with DM2 is higher than expected (OR = 1.6–2.0) (Anderson et al., 2001; Ali et al., 2006) and vice versa (RR= 1.29–1.72) (Vancampfort et al., 2015).”
BackgroundInfluentialDowlati, Y., Herrmann, N., Swardfager, W. L., Reim, E. K., & Lanctôt, K. L. (2010) · The Canadian Journal of Psychiatry · doi:10.1177/070674371005500205 · Cited by 79 · cited 2×
“Dowlati and colleagues undertook a detailed meta-analysis of the occurrence of raised pro- inflammatory cytokines in major depression and concluded that tumour necrosis factor alpha (TNF-α) and interleukin 6 (IL6) were generally raised in comparison to control subjects (Dowlati et al., 2010).”
BackgroundKöhler-Forsberg, O., Sylvia, L., Deckersbach, T., Ostacher, M. J., McInnis, M., Iosifescu, D., Bowden, C., McElroy, S., Calabrese, J., Thase, M., et al. (2018) · Acta Neuropsychiatrica · doi:10.1017/neu.2017.34 · Cited by 15
Role of metabolic dysfunction in treatment resistance of major depressive disorder
Toups, M. S., & Trivedi, M. H. (2011) · Neuropsychiatry · doi:10.2217/npy.11.49 · Cited by 9
Cited by
Allostasis, action and affect in depression: Insights from the theory of constructed emotion
Shaffer, C., Westlin, C., Quigley, K. S., Whitfield-Gabrieli, S., & Barrett, L. F. (2022) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-081219-115627 · Cited by 94
Sen, Z. D., Danyeli, L. V., Woelfer, M., Lamers, F., Wagner, G., Sobanski, T., & Walter, M. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.12.020 · Cited by 65
Garcia-Argibay, M., Li, L., Du Rietz, E., Zhang, L., Yao, H., Jendle, J., Ramos-Quiroga, J. A., Ribasés, M., Chang, Z., Brikell, I., et al. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105076 · Cited by 52
“For example, depression has been shown to affect the way the body processes insulin, which is a hormone that plays a key role in regulating blood sugar levels (Kan et al., 2013; Leonard and Wegener, 2020).”
Rashidian, H., Subramaniapillai, M., Park, C., Lipsitz, O., Zuckerman, H., Cao, B., Lee, Y., Gill, H., Rodrigues, R. N., Di Vincenzo, J. D., et al. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811221132473 · Cited by 23
“This can potentially be explained by the fact that in the context of IR, glucose transport across the blood–brain barrier is decreased (Leonard and Wegener, 2019).”
Background
Metadata
- Authors
- Leonard, B. E., & Wegener, G.
- Venue
- Acta Neuropsychiatrica
- Publisher
- Cambridge University Press (CUP)
- Published
- 2019-06-12
- Volume
- 32
- Issue
- 1
- Pages
- 1-9
- ISSN
- 0924-2708 (ISSN-L)
- 1601-5215
- OpenAlex
- W2950041915
- Cited by
- 116
- References
- 29
- FWCI
- 2.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.